Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...

Few autoimmune disorders are more challenging for patients than multiple sclerosis, a progressive condition that can affect ...

Doctors at Jewish Hospital Mercy Health are pioneering a new approach to treating multiple sclerosis (MS), offering hope to ...

Hope Biosciences' stem cell therapy led to improved scores on a quality-of-life test for MS patients in a small clinical trial.

Genenetch: “Medication Guide: Ocrevus.” Annals of Neurology: “B Cell Therapy for Multiple Sclerosis: Entering an Era.” PLOS ONE: “Long-term safety of rituximab induced peripheral B-cell ...

If you have MS, some B cells enter your brain and spinal cord ... You’ll receive two doses, 2 weeks apart. Then you’ll get one dose every 6 months. Ofatumumab (Kesimpta) is a shot you give ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...

Researchers at the Wellcome Sanger Institute and Newcastle University, together with a team of international collaborators, have created a single-cell atlas of prenatal human skin, and a “mini ...

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

In a study published Sept. 27 in the journal Science Immunology, researchers studied the T cells of 12 pairs of identical twins. In each pair, one twin had MS and the other did not. When one twin ...